Repare Therapeutics Inc. (RPTX) Misses Q1 EPS by 2c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q1 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81). Revenue for the quarter came in at $5.67 million versus the consensus estimate of $5.14 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79